1Stewart LA,Pignon JP.Chemotherapy in non-small cell lung cancer:a meta-analysis using updated data on individual patients from 52 randomised clinical trials[J].BMJ,1995,311:899-909.
2Keller SM,Adak S,Wagner H,et al.A randomized trial of postoperative adjuvant therapy in patients with completely resected stage Ⅱ or ⅢA non-small-cell lung cancer[J].N Engl J Med,2000,343(17):1217-1222.
3Scagliotti GV,Fossati R,Torri V,et al.Randomized study of adjuvant chemotherapy for completely resected stage I,Ⅱ,or ⅢA non-small-cell Lung cancer[J].J Natl Cancer Inst,2003,95(19):1453-1461.
4Arriagada R,Bergman B,Chevalier T,et.al.Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer[J].N Engl J Med,2004,350(4):351-360.
5Waller D,Peake MD,Stephens RJ,et al.Chemotherapy for patients with non-small cell lung cancer:the surgical setting of the Big Lung Trial[J].Eur J Cardiothorac Surg,2004,26(1):173-182.
6Kato H,Ichinose Y,Ohta M,et al.A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung[J].N Engl J Med,2004,350(17):1713-1721.
7Winton T,Livingston R,Johnson D,et al.Vinorelbine plus cisplatin vs.observation in resected non-small-cell lung cancer[J].N Engl J Med,2005,352(25):2589-2597.
8Rosell R,Cuello M,Cecere F,et al.Treatment of non-small-cell lung cancer and pharmacogenomics:where we are and where we are going[J].Curr Opin Oncol,2006,18(2):135-134.
9Ramaswamy B,Puhalla S.Docetaxel:a tubulin-stabilizing agent approved for the management of several solid tumors[J].Drugs Today (Barc),2006,42(4):265-279.
10Rosell R,Fossella F,Milas L.Molecular markers and targeted therapy with novel agents:prospects in the treatment of non-small cell lung cancer[J].Lung Cancer,2002,38(Suppl 4):43-49.
